batirtze-areitio Batirtze Areitio Batirtze has over 5 years of experience in the biopharma and biotech industries. She joined ApexOnco in 2025 after working as an analyst at OncologyPipeline. She is a graduate of the University of Navarra, where she earned a degree in biochemistry. Xencor “still committed” to oncology 9 September 2024 IN8bio cuts costs on registrational delay 5 September 2024 Innovent revives its US checkpoint plan 4 September 2024 Daiichi broadens its Vanflyta net 2 September 2024 Imugene goes for a cytokine boost 2 September 2024 Next up for SHP2: partner buy-in 30 August 2024 Repare shelves its early work 29 August 2024 Two Keytruda setbacks in early cancer settings 29 August 2024 Load More